It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Explore the best cash back credit cards available to maximize your rewards and savings. Learn how to choose the right card for you.
28,074 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
At New Delhi's AI Impact Summit, a staged gesture exposed rivalries among top AI leaders, triggering a rethink of AI ...
The Social Security Fairness Act repeals the Windfall Elimination Provision and Government Pension Offset, boosting a...
Even with a stunning 19x profit surge, Samsung's stock slipped. This article breaks down why the market reacted this ...
Pershing Square disclosed a single new equity position this quarter: Meta Platforms. The bet is large enough to tilt ...
A fresh round of political headlines rattled major indices, but three forgotten micro-cap stocks under $30 surged on ...
Investors gauge SpaceX’s potential public listing amid a cautious IPO market. History from Meta’s debut suggests hype...
A high-net-worth retiree explains why testing retirement before quitting matters and outlines a disciplined, income-f...
Berkshire Hathaway sold stocks in Q1, exiting 16 positions as the conglomerate maintains a heavy concentration in sev...
As the IoT market expands, Synaptics is recalibrating its business to capture devices beyond smartphones. This deep d...
A broad market rally lifted major indexes on Feb. 24 as traders anticipated Nvidia’s earnings and awaited remarks fro...
Shrey Parikh outpaced rivals in a tense lightning-round finale, spelling 32 words correctly in 90 seconds to become t...